Search
Filter your results
- All
- News
- Opinion
- Commentary
- Media Miss
Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights
Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected.
Weight loss drug Wegovy can reduce heart attack risk, study says
The weight loss drug Wegovy has become wildly popular, and the health benefits go beyond just dropping pounds, according to new data released by the drugmaker. Results of the clinical trial released on Tuesday, Aug. 8, suggests the supplement, used for quickly losing weight, directly coincides with a lower risk of heart disease by as…
Weight loss drugs Ozempic, Wegovy subject of multiple investigations
Ozempic and Wegovy, drugs typically used to treat Type 2 diabetes, are now commonly accepted as weight loss drugs. They’ve gained major traction as a trendy way to drop pounds fast with celebrities promoting them and the masses buying in. But there are new health-related warnings issued to the weight loss method. According to a…
Weather troubles: Tornado hits Pfizer plant; heat makes Delta passengers sick
Severe weather continues to take hold over the United States during the week of July 16, with a tornado hitting a Pfizer plant in North Carolina and passengers on a Delta flight getting sick due to the Las Vegas heat. The tornado hit just after midday on Wednesday, July 20. There were no serious reports…
Eli Lilly slashes insulin prices as low as $25 per vial
A major pharmaceutical company in the U.S. is making it easier for diabetics to access affordable insulin. Eli Lilly and Co. announced Wednesday a 70% price reduction to its most commonly prescribed insulins and expanded its program that caps out-of-pocket expenses for patients at $35 a month. The announcement comes as the federal government, as…
PM rundown: Sen. Sasse steps down, Iran executes more protesters
An outgoing senator leaves a Senate vacancy to fill; a ban on bump stocks has been struck down by an appeals court; and children who are obese are now recommended to take weight-loss medication. These stories and more highlight your midday rundown for Monday, Jan. 9, 2023. Sen. Ben Sasse steps down Republican Sen. Ben…
Celebrity endorsements lead to diabetes medicine Ozempic shortage
There’s a shortage of the diabetes drug Ozempic due to people using it for weight loss. The shortage is making it harder for diabetics to find the important medicine. Ozempic helps people with type two diabetes lower their blood sugar and A1C. Ozempic is the brand name for semaglutide, which stimulates insulin secretion and helps…
Study links artificial sweeteners to risk of heart disease
A new study out of France has experts worried that artificial sweeteners are not the healthiest alternative to sugar. French researchers have found what they are calling a link between the use of these sugar substitutes and increased risk of heart disease. The study of 103,000 French adults led by researchers from the Sorbonne Paris…
US diabetics paying more for insulin as price continues to rise
Over the weekend, the Senate passed the Democrats’ climate change and health care bill by the narrowest of margins. One provision in the original bill that was stripped out was a federally mandated $35 cap on the price of insulin. The exclusion of the mandate made headlines as reporters, lawmakers and activists pointed out that…
CDC estimates 28% rise in drug overdose deaths, fueled by fentanyl
According to data on overdose deaths released Wednesday by the Centers for Disease Control and Prevention, 100,306 Americans died from an overdose between April 2020 and April 2021. The estimate is not an official count. Since it can take many months for death investigations involving drug fatalities to become final, the CDC made the estimate…
Welcome back to trustworthy journalism.
Here at Straight Arrow News, we…
Report without partisan spin, earning distinctions from media bias experts at AllSides and Ad Fontes
Share what other news outlets are underreporting with our Media Miss™ tool
Provide perspective with opinions and commentary from all sides